PLAA
Gene Information
- Official Symbol: PLAA
- Official Name: phospholipase A2 activating protein
- Aliases and Previous Symbols: N/A
- Entrez ID: 9373
- UniProt: Q9Y263
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: Plays a role in protein ubiquitination, sorting and degradation through its association with VCP (PubMed:27753622). Involved in ubiquitin-mediated membrane proteins trafficking to late endosomes in an ESCRT-dependent manner, and hence plays a role in synaptic vesicle recycling (By similarity). May play a role in macroautophagy, regulating for instance the clearance of damaged lysosomes (PubMed:27753622). Plays a role in cerebellar Purkinje cell development (By similarity). Positively regulates cytosolic and calcium-independent phospholipase A2 activities in a tumor necrosis factor alpha (TNF-alpha)- or lipopolysaccharide (LPS)-dependent manner, and hence prostaglandin E2 biosynthesis (PubMed:18291623, PubMed:28007986). {ECO:0000250|UniProtKB:P27612, ECO:0000269|PubMed:18291623, ECO:0000269|PubMed:27753622, ECO:0000269|PubMed:28007986}.
Pfam Domains GO Terms
Pfam Domains
| PUL |
| WD40 |
| PFU |
GO Terms
| phospholipase A2 activator activity |
| negative regulation of protein K63-linked ubiquitination |
| positive regulation of phospholipase A2 activity |
| ubiquitin recycling |
| negative regulation of protein polyubiquitination |
| positive regulation of synaptic vesicle recycling |
| regulation of protein K63-linked ubiquitination |
| regulation of phospholipase A2 activity |
| positive regulation of neuron migration |
| regulation of protein polyubiquitination |
| ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway |
| positive regulation of dendrite extension |
| regulation of synaptic vesicle recycling |
| regulation of dendrite extension |
| prostaglandin metabolic process |
| prostanoid metabolic process |
| regulation of neuron migration |
| positive regulation of phospholipase activity |
| regulation of phospholipase activity |
| positive regulation of lipase activity |
| negative regulation of protein ubiquitination |
| ubiquitin binding |
| negative regulation of protein modification by small protein conjugation or removal |
| regulation of lipase activity |
| unsaturated fatty acid metabolic process |
| icosanoid metabolic process |
| regulation of synaptic vesicle cycle |
| macroautophagy |
| positive regulation of cell growth |
| fatty acid derivative metabolic process |
| positive regulation of developmental growth |
| cellular response to lipopolysaccharide |
| cellular response to molecule of bacterial origin |
| regulation of protein ubiquitination |
| cellular response to biotic stimulus |
| regulation of protein modification by small protein conjugation or removal |
| positive regulation of growth |
| process utilizing autophagic mechanism |
| autophagy |
| synapse |
| positive regulation of neuron projection development |
| response to lipopolysaccharide |
| fatty acid metabolic process |
| proteasome-mediated ubiquitin-dependent protein catabolic process |
| response to molecule of bacterial origin |
| regulation of developmental growth |
| proteasomal protein catabolic process |
| positive regulation of neuron differentiation |
| phospholipid metabolic process |
| positive regulation of cell projection organization |
| regulation of cell growth |
| positive regulation of neurogenesis |
| regulation of cell morphogenesis |
| regulation of neuron projection development |
| inflammatory response |
| positive regulation of cell migration |
| cellular response to lipid |
| positive regulation of cell motility |
| ubiquitin-dependent protein catabolic process |
| monocarboxylic acid metabolic process |
| modification-dependent protein catabolic process |
| positive regulation of nervous system development |
| positive regulation of cellular component movement |
| positive regulation of cell development |
| modification-dependent macromolecule catabolic process |
| cell junction |
| regulation of vesicle-mediated transport |
| positive regulation of locomotion |
| proteolysis involved in cellular protein catabolic process |
| negative regulation of protein modification process |
| cellular protein catabolic process |
| regulation of neuron differentiation |
| regulation of growth |
| protein catabolic process |
| response to bacterium |
| regulation of plasma membrane bounded cell projection organization |
| regulation of cell projection organization |
| positive regulation of hydrolase activity |
| regulation of neurogenesis |
| regulation of cell migration |
| response to lipid |
| organophosphate metabolic process |
| cellular homeostasis |
| cellular macromolecule catabolic process |
| carboxylic acid metabolic process |
| regulation of cell motility |
| regulation of cellular localization |
| regulation of nervous system development |
| regulation of cell development |
| cellular lipid metabolic process |
| positive regulation of cell differentiation |
| regulation of locomotion |
| positive regulation of transport |
| regulation of cellular component movement |
| oxoacid metabolic process |
| organic acid metabolic process |
| negative regulation of cellular protein metabolic process |
| macromolecule catabolic process |
| cellular response to oxygen-containing compound |
| organonitrogen compound catabolic process |
| regulation of anatomical structure morphogenesis |
| negative regulation of protein metabolic process |
| positive regulation of cellular component organization |
| lipid metabolic process |
| proteolysis |
| regulation of hydrolase activity |
| response to other organism |
| response to external biotic stimulus |
| response to biotic stimulus |
| defense response |
| positive regulation of developmental process |
| positive regulation of catalytic activity |
| generation of neurons |
| response to oxygen-containing compound |
| neurogenesis |
| homeostatic process |
| positive regulation of multicellular organismal process |
| small molecule metabolic process |
| organic substance catabolic process |
| positive regulation of molecular function |
| cellular catabolic process |
| regulation of cell differentiation |
| regulation of protein modification process |
| regulation of transport |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| BAK1 | 0.759 |
| APAF1 | 0.756 |
| UBQLN1 | 0.741 |
| CASP9 | 0.718 |
| FAF2 | 0.693 |
| MARCH5 | 0.688 |
| VDAC2 | 0.674 |
| DOHH | 0.665 |
| RAD23B | 0.661 |
| DIABLO | 0.634 |
| HARS | 0.629 |
| HSPD1 | 0.617 |
| CYCS | 0.609 |
| HCCS | 0.606 |
| GFPT1 | 0.59 |
| ENY2 | 0.586 |
| RPTOR | 0.581 |
| THG1L | 0.58 |
| TRIAP1 | 0.577 |
| UBE2K | 0.577 |
| SERF2 | 0.571 |
| UBE2G2 | 0.553 |
| ROMO1 | 0.549 |
| KDSR | 0.542 |
| UAP1 | 0.539 |
| ATAD1 | 0.537 |
| MTOR | 0.535 |
| GMPPB | 0.53 |
| GABPA | 0.529 |
| MEAF6 | 0.528 |
| MFN1 | 0.522 |
| RTCB | 0.516 |
| BAP1 | 0.514 |
| RNMT | 0.511 |
| ATP5J | 0.51 |
| PMM2 | 0.508 |
| ALG1 | 0.503 |
| STAU1 | 0.503 |
| NSD1 | 0.499 |
| OPA1 | 0.49 |
| WDR59 | 0.485 |
| PPP2R3C | 0.484 |
| NXT1 | 0.483 |
| ZZZ3 | 0.482 |
| WDR24 | 0.482 |
| TRIM28 | 0.482 |
| TAZ | 0.48 |
| NAE1 | 0.477 |
| METAP2 | 0.476 |
| UBA3 | 0.476 |
| CTDNEP1 | 0.474 |
| DPAGT1 | 0.469 |
| PELO | 0.466 |
| SEC63 | 0.465 |
| ATP5I | 0.465 |
| PPP5C | 0.463 |
| CRLS1 | 0.455 |
| GTF3C3 | 0.454 |
| CSNK2B | 0.454 |
| TIMM13 | 0.452 |
| SRP14 | 0.45 |
| KCTD5 | 0.448 |
| PAM16 | 0.446 |
| TAMM41 | 0.444 |
| ATP5O | 0.444 |
| DHPS | 0.443 |
| CCT7 | 0.442 |
| GTF3A | 0.441 |
| NUPL2 | 0.438 |
| ALG2 | 0.438 |
| RPE | 0.438 |
| CBFB | 0.438 |
| MLST8 | 0.437 |
| VHL | 0.435 |
| RPN1 | 0.432 |
| ELF2 | 0.432 |
| SLC25A26 | 0.431 |
| PPA2 | 0.43 |
| VEZT | 0.429 |
| EXOC4 | 0.427 |
| ATP5B | 0.427 |
| PDPK1 | 0.426 |
| DDHD2 | 0.426 |
| GTF3C4 | 0.426 |
| PISD | 0.425 |
| AUP1 | 0.424 |
| ATP5A1 | 0.424 |
| UBXN7 | 0.422 |
| DR1 | 0.42 |
| SEH1L | 0.419 |
| BPTF | 0.419 |
| EIF3F | 0.418 |
| GTF3C6 | 0.417 |
| BRWD1 | 0.417 |
| ENO1 | 0.416 |
| SEC61G | 0.415 |
| UTP23 | 0.414 |
| FECH | 0.412 |
| UBE2J1 | 0.411 |
| VMP1 | 0.41 |
| ATP2A2 | 0.409 |
| DAD1 | 0.408 |
| TAF4 | 0.407 |
| PHB | 0.406 |
| ATXN10 | 0.406 |
| EIF4E | 0.405 |
| ORAOV1 | 0.404 |
| TMED10 | 0.403 |
| TMEM41B | 0.401 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 1/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 1/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 15979
- Expression level (log2 read counts): 5.48
Expression Distribution
PLAA Expression in NALM6 Cells: 5.48